Make that 2 new US Big Pharma chiefs today, as Novartis remakes top team
Today we get two new Big Pharma chiefs for the US market.
This morning GlaxoSmithKline led the way with the news that they recruited Merck KGaA’s Maya Martinez-Davis for the role of US pharma president. And Novartis, which has been remaking its own top ranks, followed by announcing that Fabrice Chouraqui is stepping down from that same role and will be replaced by Victor Bulto, who has championed Cosentyx in the US.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 84,700+ biopharma pros reading Endpoints daily — and it's free.